Skip to main content
Equibles
AORT logo

AORT · Artivion, Inc.

Track AORT — free

Use AORT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$25.57 -0.05 (-0.20%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.25B
Shares
48.76M

AORT metrics

85 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$25.57
Market cap
$1.25B

Price action

19 metrics
Price change (1W)
-4.5%
Price change (30D)
-5.7%
Price change (3M)
+27.1%
Price change (6M)
-31.0%
Price change (YTD)
-43.9%
Price change (1Y)
-41.9%
Trailing year
Price change (5Y)
-0.8%
52-week high
$47.63
52-week low
$20.10
Change from 52-week high
-46.3%
Change from 52-week low
+27.2%
Annualized volatility
48.1%
Beta
0.3
RSI (14D)
41.4
Price vs SMA 50
-1.9%
Price vs SMA 200
-24.2%
Avg volume (3M)
731,196
Relative volume
0.6
Average dollar volume
$18.10M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
48.76M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.2×
reciprocal yield 30.9%
EV / EBITDA
33.8×
reciprocal yield 3.0%
EV / EBIT
73.9×
reciprocal yield 1.4%
P / sales
2.6×
reciprocal yield 38.0%
P / book
2.8
reciprocal yield 35.9%
FCF yield
-0.7%
TTM · current market cap
Buyback yield
0.4%
P / FCF
—
P / operating cash flow
29.7
reciprocal yield 3.4%
Earnings yield
-0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.7×
reciprocal yield 26.8%
EV / revenue historical average (5Y)
3.5×
reciprocal yield 28.9%
EV / EBIT historical average (3Y)
77.7×
reciprocal yield 1.3%
EV / EBIT historical average (5Y)
156.6×
reciprocal yield 0.6%
EV / EBITDA historical average (3Y)
32.1×
reciprocal yield 3.1%
EV / EBITDA historical average (5Y)
33.2×
reciprocal yield 3.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
64.4%
Operating margin
4.4%
Trailing 12 months
Net margin
-0.7%
Gross profit (TTM)
$303.50M
Operating profit (TTM)
$20.64M
Net income (TTM)
−$3.17M
Trailing 12 months
Diluted EPS (TTM)
$-0.06
FCF margin
-1.9%
Effective tax rate
241.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+11.3%
Year over year
Net income growth YoY
-1,104.5%
Revenue (TTM)
$471.47M
Trailing 12 months
EPS growth YoY
-1,033.3%
Shares change YoY
+7.0%
Year over year · more shares
Revenue CAGR (3Y)
+12.0%
Revenue CAGR (5Y)
+11.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-30.1%

Quality

14 metrics
Return on equity
-0.7%
Return on assets
-0.3%
Debt / equity
0.8
Current ratio
3.5
EBITDA (TTM)
$45.20M
Free cash flow (TTM)
−$9.16M
Quick ratio
2.5
Interest coverage
0.9
Net debt / EBITDA
6.3
Return on invested capital
—
Trailing 12 months
Net cash
−$286.11M
Latest balance sheet
Cash & equivalents
$77.32M
Total assets
$1.07B
Total debt
$363.42M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$41.71M
Capital expenditures (TTM)
$50.87M
R&D (TTM)
$35.10M
SG&A (TTM)
$254.77M
Stock compensation (TTM)
$26.80M
R&D / revenue
7.4%
Stock compensation / revenue
5.7%

Ownership (13F)

3 metrics
13F filers
207
13F filer change QoQ
-32
Institutional ownership
94.2%

Short interest

3 metrics
Short interest
5.6%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.22M
Insider-sentiment score
16 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 784199 CUSIP 228903100 13F (30d) 147 filings 147 filers Visit website Investor relations